— Know what they know.
Not Investment Advice

LYCA Short Interest

Lycia Therapeutics Inc.
YTD: -13.0%
$26.11
-2.74 (-9.50%)
Pre-Market: $25.25 (-0.86, -3.31%)
NASDAQ · Healthcare · Biotechnology · $1.4B mcap · 7M float · 30.83% daily turnover · Short 32% of daily vol
Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
38.3%
Short Ratio
of total volume
32.4%
20-Day Avg
32.4%
50-Day Avg
— Flat
5-Day Trend
0.2M
Short Volume
0.6M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 203,232 541,551 37.5%
NYSE 11,894 24,182 49.2%
BATS 3,024 3,463 87.3%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms